| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.80▼ | 3.83▼ | 3.86▼ | 3.88▼ | 4.01▼ |
| MA10 | 3.84▼ | 3.88▼ | 3.89▼ | 3.96▼ | 3.73▲ |
| MA20 | 3.89▼ | 3.91▼ | 3.90▼ | 4.10▼ | 3.40▲ |
| MA50 | 3.90▼ | 3.98▼ | 4.05▼ | 3.74▲ | 3.10▲ |
| MA100 | 4.05▼ | 4.13▼ | 4.12▼ | 3.39▲ | 2.86▲ |
| MA200 | 4.13▼ | 4.03▼ | 3.88▼ | 3.18▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.013▼ | -0.010▼ | -0.004▼ | -0.074▼ | 0.055▲ |
| RSI | 37.770▼ | 37.943▼ | 38.741▼ | 42.694▼ | 58.387▲ |
| STOCH | 7.210▼ | 14.960▼ | 14.815▼ | 14.612▼ | 73.282 |
| WILL %R | -89.130▼ | -90.000▼ | -90.000▼ | -100.000▼ | -51.648 |
| CCI | -99.157 | -131.511▼ | -149.721▼ | -95.230 | 58.858 |
|
Thursday, October 16, 2025 08:55 AM
In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to enroll 15 newly diagnosed metastatic and 15 newly diagnosed locally-advanced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 3.93 | 3.99 | 3.75 | 3.75 | 50,560 |
| 16/10/25 | 3.90 | 4.04 | 3.7511 | 3.89 | 69,472 |
| 15/10/25 | 3.91 | 4.04 | 3.835 | 3.87 | 57,346 |
| 14/10/25 | 3.75 | 4.0778 | 3.75 | 3.97 | 28,090 |
| 13/10/25 | 3.80 | 4.25 | 3.79 | 3.93 | 21,077 |
| 10/10/25 | 3.86 | 4.09 | 3.75 | 3.78 | 93,826 |
| 09/10/25 | 4.17 | 4.2899 | 3.76 | 3.87 | 144,305 |
| 08/10/25 | 4.14 | 4.45 | 4.10 | 4.17 | 31,926 |
| 07/10/25 | 4.21 | 4.21 | 4.11 | 4.13 | 9,855 |
| 06/10/25 | 4.35 | 4.3629 | 4.065 | 4.22 | 89,997 |
|
|
||||
|
|
||||
|
|